SCHEMBL18734953

SCHEMBL18734953

CCOC(=O)CC(=O)C(=O)SC(C)C(NC(=O)C(C)CC)C(=O)N(CC)CC

nearest known ligand 0.32

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ MGAM O43451 1/20 0.32
▸ GAA P10253 1/20 0.32
▸ SI P14410 1/20 0.32
▸ MGAM2 Q2M2H8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18734958 0.91 MGAM (0.33) MGAMGAASIMGAM2
SCHEMBL18734972 0.91 — —
SCHEMBL18734961 0.88 — —
SCHEMBL18735172 0.88 MGAM (0.33) MGAMGAASIMGAM2
SCHEMBL18734952 0.86 MGAM (0.33) MGAMGAASIMGAM2
SCHEMBL18734946 0.81 — —
SCHEMBL18734956 0.81 MGAM (0.32) MGAMGAASIMGAM2
SCHEMBL18735378 0.81 METAP2 (0.32) —
SCHEMBL18734971 0.79 — —
SCHEMBL18735351 0.79 METAP2 (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017060400-A1 PROTECTED CARBOXYLIC ACID-BASED METABOLITES FOR THE TREATMENT OF DISESASES RELATED TO MITOCHONDRIAL DYSFUNCTIONS NEUROVIVE PHARMACEUTICAL AB (SE) 2017-04-13 — — WO disclosed
Send feedback